D Krenová Selected Research

Lipids

1/2005	A 14-gene region of rat chromosome 8 in SHR-derived polydactylous congenic substrain affects muscle-specific insulin resistance, dyslipidaemia and visceral adiposity.
1/2002	Rosiglitazone improves insulin resistance, lipid profile and promotes adiposity in a genetic model of metabolic syndrome X.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

D Krenová Research Topics

Disease

4	Insulin Resistance 01/2006 - 01/2000
2	Dyslipidemias (Dyslipidemia) 01/2006 - 01/2002
2	Glucose Intolerance 01/2002 - 01/2000
1	Body Weight (Weight, Body) 01/2005
1	Polydactyly (Polydactylism) 01/2005
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2002
1	Hypertension (High Blood Pressure) 01/2000

Drug/Important Bio-Agent (IBA)

2	Insulin (Novolin)FDA Link 01/2006 - 01/2002
2	Sucrose (Saccharose)IBA 01/2006 - 01/2002
2	Triglycerides (Triacylglycerol)IBA 01/2006 - 01/2002
2	LipidsIBA 01/2005 - 01/2002
1	CarbohydratesIBA 01/2006
1	CholesterolIBA 01/2006
1	Glucose (Dextrose)FDA LinkGeneric 01/2006
1	Nonesterified Fatty Acids (NEFA)IBA 01/2002
1	Rosiglitazone (Avandia)FDA Link 01/2002
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2000